Evidence map›Paper›PMID 23610082›Full record

ArticleDiabetes care2013

Factors associated with microalbuminuria in 7,549 children and adolescents with type 1 diabetes in the T1D Exchange clinic registry.

Mark Daniels, Stephanie N DuBose, David M Maahs, Roy W Beck, Larry A Fox, Rose Gubitosi-Klug, Lori M Laffel, Kellee M Miller, Heather Speer, William V Tamborlane and 2 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Diabetes care, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03835312 (Sequential Transplantation of Umbilical Cord Blood Stem Cells and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency Type 1 Diabetes Mellitus), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03835312 narecruitingnot on this mapstarted 2019, after this paper: background citation

Sequential Transplantation of Umbilical Cord Blood Stem Cells and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency Type 1 Diabetes Mellitus

TypeinterventionalSponsorChildren's Hospital of Fudan UniversityRan2019 to 2030Enrolled50ConditionsDiabetes Mellitus, Type 1, Immunologic Deficiency SyndromesArmsSequential transplantation
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Renal Complications and Duration of Diabetes: An International Comparison in Persons with Type 1 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021
    Article
  13. Review
  14. Hemostatic state of children with type 1 diabetes.Annals of pediatric endocrinology & metabolism · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Mark DanielsChildren’s Hospital of Orange County, Orange, California, USA.
Stephanie N DuBose
David M Maahs
Roy W Beck
Larry A Fox
Rose Gubitosi-Klug
Lori M Laffel
Kellee M Miller
Heather Speer
William V Tamborlane
Michael J Tansey
T1D Exchange Clinic Network
Jaeb Center for Health Research · USChildren's Hospital of Orange County · USJoslin Diabetes Center · USNemours Children's Clinic · USRainbow Babies & Children's Hospital · USUniversity of Iowa · USUniversity of New Haven · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
NCATS NIH HHS UL1 TR000439
6 · The paper itself

Abstract

objectiveTo examine factors associated with clinical microalbuminuria (MA) diagnosis in children and adolescents in the T1D Exchange clinic registry. RESEARCH DESIGN AND

methodsT1D Exchange participants <20 years of age with type 1 diabetes ≥ 1 year and urinary albumin-to-creatinine ratio (ACR) measured within the prior 2 years were included in the analysis. MA diagnosis required all of the following: 1) a clinical diagnosis of sustained MA or macroalbuminuria, 2) confirmation of MA diagnosis by either the most recent ACR being ≥ 30 mg/g or current treatment with an ACE inhibitor (ACEI) or angiotensin receptor blocker (ARB), and 3) no known cause for nephropathy other than diabetes. Logistic regression was used to assess factors associated with MA.

resultsMA was present in 329 of 7,549 (4.4%) participants, with a higher frequency associated with longer diabetes duration, higher mean glycosylated hemoglobin (HbA1c) level, older age, female sex, higher diastolic blood pressure (BP), and lower BMI (P ≤ 0.01 for each in multivariate analysis). Older age was most strongly associated with MA among participants with HbA1c ≥ 9.5% (≥ 80 mmol/mol). MA was uncommon (<2%) among participants with HbA1c <7.5% (<58 mmol/mol). Of those with MA, only 36% were receiving ACEI/ARB treatment.

conclusionsOur results emphasize the importance of good glycemic and BP control, particularly as diabetes duration increases, in order to reduce the risk of nephropathy. Since age and diabetes duration are important nonmodifiable factors associated with MA, the importance of routine screening is underscored to ensure early diagnosis and timely treatment of MA.

Indexed as

AdolescentAdultAlbuminuriaBlood GlucoseBlood PressureChildChild, PreschoolDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansMaleRisk FactorsYoung AdultBlood GlucoseGlycated Hemoglobin

Identifiers

PMID23610082
PMCPMC3747908
OpenAlexW2012959319

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.